Serotonin toxicity from antidepressant overdose and its association with the T102C polymorphism of the 5-HT2A receptor

被引:0
作者
J M Cooper
D A Newby
I M Whyte
G Carter
A L Jones
G K Isbister
机构
[1] Discipline of Clinical Pharmacology,Department of Clinical Toxicology and Pharmacology
[2] University of Newcastle,Department of Liaison Psychiatry
[3] Discipline of Pharmacy and Experimental Pharmacology,undefined
[4] University of Newcastle,undefined
[5] Calvary Mater Newcastle,undefined
[6] Calvary Mater Newcastle,undefined
[7] Graduate School of Medicine,undefined
[8] University of Wollongong,undefined
来源
The Pharmacogenomics Journal | 2014年 / 14卷
关键词
genotype; 5HT2A; polymorphism; serotonin 2A receptor; serotonin syndrome; serotonin toxicity;
D O I
暂无
中图分类号
学科分类号
摘要
Serotonin toxicity results from serotonin excess in the central nervous system from serotonergic drugs. Previous studies suggest an association between T102C polymorphism of the serotonin 2A (5-hydroxytryptamine 2A) receptor gene and serotonergic adverse effects with serotonergic drugs. We aimed to determine whether there is an association between the T102C polymorphism and serotonin toxicity in patients taking serotonergic drug overdoses. Ninety-five patients presenting with serotonergic drug overdoses were examined for serotonin toxicity and had blood collected for DNA analysis. A diagnosis of serotonin toxicity was made in 14 patients (15%) based on the Hunter Serotonin Toxicology Criteria. Four of the 14 patients (29%) with serotonin toxicity had the C/C genotype compared with 20/81 (25%) without serotonin toxicity. There were no differences in age or sex, but the median defined daily dose taken by patients with serotonin toxicity was 27 (14–84) compared with 18 (2–136) in patients without serotonin toxicity (P=0.06). There was no association between serotonin toxicity and the T102C polymorphism in patients taking a serotonergic drug overdose.
引用
收藏
页码:390 / 394
页数:4
相关论文
共 179 条
[1]  
Wong DT(1975)A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine J Pharmacol Exp Ther 193 804-811
[2]  
Bymaster FP(2001)5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential Eur J Pharmacol 420 103-112
[3]  
Horng JS(2007)High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity J Med Chem 50 5024-5033
[4]  
Molloy BB(1998)F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential J Pharmacol Exp Ther 287 266-283
[5]  
Koek W(2007)Serotonin toxicity: a practical approach to diagnosis and treatment Med J Aust 187 361-365
[6]  
Vacher B(2008)How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems Neuropharmacology 55 932-960
[7]  
Cosi C(2005)HTR2A: association and expression studies in neuropsychiatric genetics Ann Med 37 121-129
[8]  
Assie MB(2001)Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression Neurosci Lett 303 119-122
[9]  
Patoiseau JF(2009)5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression Neuroreport 20 1125-1128
[10]  
Pauwels PJ(2000)Serotonin-2A receptor gene is not associated with symptomatology of schizophrenia Am J Med Genet 96 84-87